Aqualyx Review
Table of content How We Researched This Aqualyx Review Aqualyx Review: What Is It? The Real FDA Approval Gap Real, Expected Side Effects — And Rarer Serious Ones A Real, Explicit Non-Weight-Loss Framing A Real Cost Consideration Does Aqualyx Work? Who Aqualyx Actually Makes Sense For Aqualyx Review: Frequently Asked Questions Aqualyx Review: The Bottom […]
The FDA has approved deoxycholic acid for fat reduction — but only in the specific form sold as Kybella, and only for fat below the chin. Aqualyx, a related but chemically distinct derivative, does not carry that same FDA approval, despite being marketed for use across the stomach, back, thighs, hips, and knees. This Aqualyx review checked what that regulatory gap actually means.
window.lightweightNewsPushAd(document.currentScript.previousElementSibling);
How We Researched This Aqualyx Review
This Aqualyx review checked the regulatory history of deoxycholic acid and Kybella specifically, the company’s own published safety data from 145 patients, and how Aqualyx’s mechanism compares to FDA-approved alternatives.
Aqualyx Review: What Is It?
Developed by Professor Pasquale Motolese and manufactured by Italy’s Marllor Biomedical, Aqualyx is an injectable, water-based fat-dissolving solution from the deoxycholate family, targeting localized fat in the stomach, back, chin, thighs, hips, and knees as a non-surgical alternative to liposuction.
What the Evidence Shows
- PRS Global Open: intralipotherapy techniques, performed properly with appropriate devices and precautions, can genuinely be effective and safe for reducing localized subcutaneous fat.
- Security and Exchange Commission filing: Aqualyx received full CE (Conformité Européene) approval in December 2012, meaning it met European Union safety testing standards.
- Company-published safety data: across 331 sessions on 145 patients, most adverse effects were mild and inflammatory, with no severe lesions, ulcers, or skin necrosis reported.
The Real FDA Approval Gap
This is the central issue worth understanding: Kybella (deoxycholic acid) received FDA approval in 2015, but strictly limited to submental (under-chin) fat. Aqualyx is a related derivative, chemically modified for slower release, but does not carry that same FDA approval — for any body area, including the many locations it’s actually marketed for. This is a real, meaningful regulatory distinction, not a technicality.
Real, Expected Side Effects — And Rarer Serious Ones
The company’s own data shows roughly 90% of patients experienced erythema (redness) or hematoma (swelling from clotted blood) — genuinely near-universal, expected effects. More serious effects reported elsewhere with deoxycholic acid compounds include nerve injury around the jaw and difficulty swallowing — real, if less common, risks worth discussing directly with a provider.
A Real, Explicit Non-Weight-Loss Framing
This is worth stating clearly, as the manufacturer itself states directly: Aqualyx is not a weight-loss product. It targets localized fat pockets for body contouring, not overall weight reduction — increased urination during treatment can create a false impression of weight loss that isn’t the product’s actual mechanism or purpose.
A Real Cost Consideration
At $395-495 per treatment, with 3-8 sessions often needed, the total cost can become substantial — though this is genuinely more affordable than FDA-approved Kybella for comparable treatment areas, a real relative value point.
Does Aqualyx Work?
For its stated purpose — localized fat contouring, not weight loss — the company’s own published data and independent research on similar techniques suggest real effectiveness with manageable, expected side effects. The lack of FDA approval for any body area is a genuine, serious regulatory gap worth weighing heavily against Kybella’s chin-specific approval.
Who Aqualyx Actually Makes Sense For
This fits people specifically seeking localized fat contouring (not weight loss) who understand and accept the FDA approval gap, working with a qualified, experienced provider. It’s a poor fit for anyone seeking actual weight loss, or anyone uncomfortable proceeding without FDA approval for the treatment area.
Frequently Asked Questions
The Bottom Line
Aqualyx has real CE approval and company-published safety data supporting its localized fat-contouring purpose, but it lacks the FDA approval that its related compound Kybella holds for chin-area use specifically. This Aqualyx review found a plausible body-contouring option with a real, serious regulatory gap worth discussing directly with a qualified provider.
Explore more Weight Loss Program reviews and guides on our site.
